Van Eck Associates Corp Sarepta Therapeutics, Inc. Transaction History

Van Eck Associates Corp

$77.4 Billion
Q1 2025

A detailed history of Van Eck Associates Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 85,918 shares of SRPT stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

85,918

Previous 84,834 1.28%

Holding current value

$1.19 Million

Previous $10.3 Million 46.84%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$63.82 - $127.89 $69,180 - $138,632	1,084 Added 1.28%	85,918 $5.48 Million
Q4 2024 Jan 29, 2025	BUY	$104.54 - $137.94 $1.74 Million - $2.3 Million	16,658 Added 24.43%	84,834 $10.3 Million
Q3 2024 Oct 29, 2024	SELL	$124.33 - $156.75 $1.86 Million - $2.34 Million	-14,930 Reduced 17.97%	68,176 $8.85 Million
Q2 2024 Jul 31, 2024	SELL	$113.33 - $163.85 $365,262 - $528,088	-3,223 Reduced 3.73%	83,106 $13.1 Million
Q1 2024 Apr 30, 2024	BUY	$93.7 - $141.53 $409,843 - $619,052	4,374 Added 5.34%	86,329 $11.2 Million
Q4 2023 Feb 05, 2024	SELL	$67.31 - $124.76 $976,668 - $1.81 Million	-14,510 Reduced 15.04%	81,955 $7.9 Million
Q3 2023 Nov 08, 2023	SELL	$102.5 - $123.59 $33,415 - $40,290	-326 Reduced 0.34%	96,465 $11.7 Million
Q2 2023 Aug 03, 2023	BUY	$106.4 - $157.19 $463,584 - $684,876	4,357 Added 4.71%	96,791 $11.1 Million
Q1 2023 May 03, 2023	BUY	$117.53 - $155.99 $10.7 Million - $14.2 Million	90,800 Added 5556.92%	92,434 $12.7 Million
Q4 2022 Feb 08, 2023	BUY	$100.86 - $132.13 $48,412 - $63,422	480 Added 41.59%	1,634 $212,000
Q3 2022 Oct 27, 2022	BUY	$75.71 - $119.24 $87,369 - $137,602	1,154 New	1,154 $128,000
Q2 2021 Aug 10, 2021	SELL	$69.38 - $86.75 $1.82 Million - $2.27 Million	-26,209 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $5.07 Million - $11.8 Million	-70,126 Reduced 72.79%	26,209 $1.95 Million
Q4 2020 Feb 09, 2021	BUY	$125.56 - $178.74 $306,240 - $435,946	2,439 Added 2.6%	96,335 $16.4 Million
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $1.56 Million - $2.11 Million	-12,268 Reduced 11.56%	93,896 $13.2 Million
Q2 2020 Aug 10, 2020	BUY	$93.0 - $171.7 $2.72 Million - $5.02 Million	29,230 Added 37.99%	106,164 $17 Million
Q1 2020 May 12, 2020	SELL	$82.38 - $131.64 $1.9 Million - $3.04 Million	-23,104 Reduced 23.1%	76,934 $7.53 Million
Q4 2019 Feb 13, 2020	SELL	$76.53 - $135.58 $100,560 - $178,152	-1,314 Reduced 1.3%	100,038 $12.9 Million
Q3 2019 Nov 08, 2019	BUY	$72.81 - $156.91 $357,642 - $770,741	4,912 Added 5.09%	101,352 $7.63 Million
Q2 2019 Aug 07, 2019	SELL	$112.21 - $151.95 $3.23 Million - $4.38 Million	-28,795 Reduced 22.99%	96,440 $14.7 Million
Q1 2019 May 13, 2019	BUY	$106.67 - $151.68 $97,069 - $138,028	910 Added 0.73%	125,235 $14.9 Million
Q4 2018 Feb 12, 2019	BUY	$97.32 - $148.76 $1.53 Million - $2.34 Million	15,763 Added 14.52%	124,325 $13.6 Million
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $12.5 Million - $17.5 Million	108,562 New	108,562 $17.5 Million

Others Institutions Holding SRPT

# of Institutions

491

Shares Held

89.6M

Call Options Held

1.39M

Put Options Held

1.11M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.21B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Sarepta Therapeutics, Inc. Transaction History